Table 2.
Predictor | B (SE) | p-value | OR | 95% CI |
---|---|---|---|---|
Medical burden X benzodiazepine use | 0.90 (0.34) | .009 | 2.45 | 1.25–4.81 |
Age | 0.007 (0.01) | .42 | 1.01 | 0.99–1.03 |
Medical burden indexa | 0.09 (0.12) | .46 | 1.09 | 0.87–1.37 |
benzodiazepine use (vs. no benzodiazepine use)b | -2.13 (1.00) | .03 | 0.12 | 0.02–0.84 |
Analyses adjusted for BDI-II scores and antipsychotic medications. The age X benzodiazepine use interaction terms was not significant (B = 0.02, SE = 0.03, p = .50), so was removed from the model
aDue to the interaction effect, this lower-order term represents the effect of medical burden index on NCI in the no benzodiazepine use reference group
bDue to the interaction effect, this lower-order term represents the effect of benzodiazepine use on NCI when medical burden index is average